2022 bbanys annual meeting schedule

Breakfast and Registration

Speaker:
Jed B. Gorlin, MD, MBA
Medical Director and Vice President, Medical and Quality Affairs
Memorial Blood Center

Abstract:
In this session, Dr. Gorlin will discuss the importance of pre-hospital transfusions to trauma victims.  Massive transfusion protocols including a discussion of ratio-driven, component-based protocols and the use of whole blood in massive transfusions are also included.

Objectives:

1. Cite findings supporting pre-hospital transfusion.
   
2. Identify controversies in MTP including fixed ratios of various components and the role of whole blood.
3. Discuss future options for plasma transfusion in this setting.
   

Speaker:
Angela Monteagle
Director of Donor Marketing, NYBC Enterprises
New York Blood Center

Abstract:
This session will provide an overview of the marketing strategies for a premier blood center, operating in over 13 states, collecting, and distributing nearly 1M blood products.  By utilizing traditional, digital, social, and call center strategies, this presentation will describe how we use these methods to achieve collection goals and meet the needs of our hospital customers and the patients they serve.

Objectives:

1. Understand how to meet distribution needs and type mix.
2. Characterize some of the critical steps in the donor experience / journey at a premier blood center.
3. Give examples of the type of marketing mediums used to acquire and retain donors.

Speaker Bio:
Angela Monteagle, Director of Donor Marketing, started her career in the blood industry at the Australian Red Cross Blood Service in 2010.  Angela worked in a national marketing role for several years before moving to manage and operate a highly efficient and productive donor center that collected red cells, platelets, and plasma, as well as managing a community blood mobile.

Angela started her career at New York Blood Center Enterprises in 2018.  In this role, she is responsible for the marketing planning, execution, and analysis across 13 states.  Her marketing strategies span traditional, digital, social to achieve collection goals to meet the needs of our hospital customers and the patients they serve.

Blood Management: Patients for Whom Blood is Not an Option

Speaker:
Himani V. Bhatt, DO, MPA, FASE, FASA
Director, Division of Cardiac Anesthesiology; Associate Professor of Anesthesiology, Perioperative & Pain Medicine; Associate Professor of Cardiovascular Surgery
Mount Sinai Morningside Medical Center, Icahn School of Medicine at Mount Sinai

Abstract:
Patient blood management is an evidence-based, multidisciplinary approach to care for patients who might need a blood transfusion.  However, for some patients blood is not an option due to religious or personal reasons.  Care of these patients requires a multidisciplinary approach throughout the entire perioperative period.  In addition, multiple strategies can be applied during the preoperative, intraoperative, and postoperative stages of their care to optimize, maintain, and preserve red cell mass to reduce morbidity and mortality.  I will be introducing patient blood management, discussing concerns for perioperative anemia, and reviewing some of these strategies for blood conservation.

Objectives:

1. Define patient blood management (PBM).
2. Discuss importance of multi-disciplinary approach to PBM for bloodless surgery.
3. Discuss concern of preoperative anemia.
4. Discuss optimization strategies for bloodless surgery.
5. Define perioperative techniques for patient management.

Speaker Bio:
Dr. Himani V. Bhatt is currently an associate professor of Anesthesiology, Perioperative and Pain Medicine at the Icahn School of Medicine at Mount Sinai and serves as the Director of Cardiac Anesthesiology at Mount Sinai Morningside Medical Center.  As a full time cardiac anesthesiologist, her clinical interests are the care of high-risk cardiac patients and surgical outcomes.  She also has a strong interest in patient blood management (PBM) and serves as the clinical liaison for Mount Sinai Systems PBM program and Chair of the PBM-Transfusion Committee at Mount Sinai Morningside Medical Center.  She is also an enthusiastic teacher for her residents and fellows and has taken part in multiple educational projects.  In addition to her clinical focus, her research interest includes topics related to use of TEE in the anesthetic management of cardiac surgical cases, evaluating outcomes in cardiac patients and anesthetic concerns in innovative fields such as electrophysiology (EP) and use of Regional anesthesia in cardiac patients.

Break and Exhibitors

Speaker:
Christine Lomas-Francis, MSc, FIBMS
Technical Director, Immunohematology Laboratory
New York Blood Center

Abstract:
This presentation will demonstrate, through case studies, the advantage of combining the use of multiple serological techniques and directed DNA-based assays for the resolution of complex antibody investigation and unexpected antigen typing results.  Understanding their potential will allow the strategic use of resources and of combining the power of DNA analysis with hemagglutination.

Objectives:

1. Describe the advanced use of serologic techniques involved in red cell antibody identification.
   
2. Discuss scenarios where DNA-based assays enhance serological investigation.
   

Speaker Bio:
Christine Lomas-Francis is the Technical Director of the lmmunohematology Laboratory of the New York Blood Center.  She is a member of the AABB, the British Blood Transfusion Society, and the International Society of Blood Transfusion among others and currently serves on the ISBT working parties for Red Cell lmmunogenetics and Blood Group Terminology and is chair of the Working Party for Rare Donors.

Exhibitors

Speaker:
Priscilla Parra, MBA, MT
Transfusion Medicine Supervisor
New York Presbyterian Hospital – Weill Cornell

Abstract:
This presentation will discuss blood management during the pandemic from the hospital perspective.

Objectives:

1. Coordinate and collaborate with blood suppliers to maintain minimal inventory levels.
2. Communicate with hospital leadership to assist implementation and enforcement of blood inventory management practices.
3. Perform prospective auditing of blood product requests that do not meet evidence-based transfusion guidelines criteria.

Speaker:
Jessica C. Shand, MD, MHS
Associate Professor, Department of Pediatrics (SMD); Associate Professor, Department of Health Humanities and Bioethics (SMD)
University of Rochester Medical Center

Abstract:
In this session, ethical decision-making as it applies to scarce resources such as blood products will be discussed.

Objectives:

1. Understand how core ethical principles apply to blood management.
   
2. Appreciate the ethical conundrums that arise when blood/blood products become scarce, and how they may be resolved.
   
3. Recognize how ostensibly value‐neutral clinical decision support algorithms may reinforce bias and health disparities, including access to blood products.

Break and Exhibitors

Speaker:
Moritz Stolla, MD, PhD
Assistant Member Bloodworks Northwest Research Institute; Associate Medical Director, Swedish Medical Center, Blood Transfusion Service
Bloodworks Northwest

Abstract:
The presentation will start with a brief review of data on the effect of temperature on platelet biology.  Next, historical data on cold-stored platelets in healthy humans and thrombocytopenic patients will be reviewed.  This will be followed by a recap of current data on in vitro and in vivo efficacy of cold-stored platelets.  Finally, the design of ongoing clinical trials will be reviewed.

Objectives:

1. Characterize effects of cold temperature on platelets.
   
2. Interpret historical data on cold-stored platelets from the literature.
   
3. Evaluate data from contemporary cold-stored platelet studies.
   
4. Recognize currently ongoing clinical trials with cold-stored platelets.
   

Speaker Bio:
Dr. Stolla's background encompasses platelet biology, transfusion medicine, and thrombosis/hemostasis.  During his research training in Dr. Bergmeier’s lab, a primary scientific focus was how platelet-signaling molecules affect platelet activation in vitro and in vivo.  This project has yielded numerous publications in reputable journals and research support from the AHA.  He joined Bloodworks in September 2016 for his first independent junior faculty position.  One of Dr. Stolla's research interests is to understand the biology of platelets exposed to cold temperatures to improve the storage platelets.  Since he joined Bloodworks, he has received numerous awards, including from ASH, AHA, NBF, DoD, and the NIH.  He has established himself as a reputable investigator in the field of basic and translational transfusion biology.

Oral Abstract Presentations

Social Networking